Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Complete Genomics; MOgene, Fluidigm; Roka Bioscience; Silicon Kinetics; Precision Biosciences; IDBS

NEW YORK (GenomeWeb News) – Investment bank Jefferies this week trimmed its 2011 and 2012 revenue forecasts for Complete Genomics after the firm recently said that it shipped fewer genomes than forecast in the fourth quarter of 2011, bringing its full-year shipments to 3,000 instead of the 3,200 that the company predicted in mid-December.

Jefferies analyst Jon Wood wrote in a research note that the bank cut its 2011 revenue forecast to $20 million from $21 million and its 2012 revenue forecast to $35 million from $40 million. He also cut the price target on Complete Genomics' stock to $7 from $12 but maintained a Buy rating.

MOgene, a genomics services provider based in St. Louis, said this week that it has added Fluidigm's Access Array sample prep technology for customers receiving targeted resequencing services.

Roka Bioscience, a spinoff of Gen-Probe, has received AOAC Performance Tested Method certification for its Listeria Detection Assay. The molecular assay runs on the firm's Atlas System, which has been developed to detect food pathogens in food and environmental samples.

San Diego-based Silicon Kinetics this week said that the Mossakowski Medical Research Center in Warsaw, Poland will serve as a demonstration site for the firm's Ski Pro system for label-free interaction analysis. The system is used to detect protein-protein, protein-drug, or protein-DNA interactions in real-time.

Precision Biosciences this week announced the formation of Precision PlantSciences, a wholly owned subsidiary focused on using Precision's Directed Nuclease Editor technology for agricultural applications. The new subsidiary will take control of all of Precision's agricultural partnerships.

IDBS has opened a new Healthcare Center of Excellence in Burlington, Mass. The Guildford, UK-based informatics firm said the center is "dedicated to the advancement of personalized medicines and improved patient outcomes through the delivery of advanced translational medicine and biomarker research informatics that bridge the worlds of clinical, molecular and image data."

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.